Consequences of timing of organic enrichment provision on pig performance, health and stress resilience after weaning and regrouping

Publication history: Accepted - 20 August 2022; Published online - 29 September 2022Most pigs in slatted systems are provided with enrichment meeting only minimum legal requirements. We aimed to explore the effects of a novel enrichment treatment consisting of daily provided fodder beet and jute bags for pigs in slatted systems, and investigate the timing of enrichment provision on performance, health and stress resilience. We used 280 weaners allocated into standard (S, meeting only legal requirements consisting of a plastic toy and softwood) or enriched (E) treatment (n = 14 groups/treatment). At regrouping during the grower to finisher transition, pigs were either kept in the same treatment (EE, SS) or switched from enriched to standard (ES) and vice versa (SE); each treatment was replicated on five groups. Pigs were weighted at the start and end of weaner, and finisher stage, and feed intake was recorded. Occurrence of scouring, respiratory problems, locomotor disorders, tail, ear, and body lesions were recorded twice a week. Ten males per treatment were sampled for saliva on days 1, 2 and 4, either postweaning or after the housing switch. Saliva samples were analysed for cortisol, alpha-amylase, haptoglobin (Hp), and adenosine deaminase. Additionally, these pigs were sampled for hair at the start and end of weaner, and end of finisher stage to analyse for hair cortisol and cortisone. We found that E weaners consumed less feed (P = 0.04), had better FCR (feed conversion ratio, P = 0.03) and less ear lesions for two weeks postweaning (P = 0.04), and tended to have lower occurrence of scouring (P = 0.07) and higher salivary cortisol concentrations (P = 0.09) than S weaners. Effects of enrichment treatment during weaner stage on performance were carried through to finisher stage, with EE and ES pigs having better FCR (P = 0.0009) and higher BW (P = 0.0001) compared to SS and SE pigs. E treatment during finisher stage decreased feed intake (P = 0.04) and tended to decrease Hp levels (P = 0.07). There was a significant interaction between enrichment treatments during weaner and finisher stages on finisher body lesions: EE finishers had less lesions than SS, ES, and SE finishers (P = 0.04). There were no other significant differences caused either by enrichment treatment during weaner/finisher stage or their interaction. We conclude that the novel enrichment applied at weaner stage had positive effects on ear lesions and performance, which were carried through to finisher stage. Body lesions were affected by its application during both stages, with finishers receiving the enrichment treatment throughout (EE) having reduced body lesions than the rest of the finishers.This research was part of the EU-China HealthyLivestock project. The authors wish to acknowledge that HealthyLivestock is funded by the European Union H2020 research and innovation programme under grant agreement number 773436. The European Commission’s support for the production of this publication does not constitute an endorsement of the contents, which reflect the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein

Controversy surrounding the increased expression of TGFβ1 in asthma

Asthma is a waxing and waning disease that leads to structural changes in the airways, such as subepithelial fibrosis, increased mass of airway smooth muscle and epithelial metaplasia. Such a remodeling of the airways futher amplifies asthma symptoms, but its etiology is unknown. Transforming growth factor β1 is a pleiotropic cytokine involved in many fibrotic, oncologic and immunologic diseases and is believed to play an essential role in airway remodeling that occurs in asthmatic patients. Since it is secreted in an inactive form, the overall activity of this cytokine is not exclusively determined by its level of expression, but also by extensive and complex post-translational mechanisms, which are all importanin modulating the magnitude of the TGFβ1 response. Even if TGFβ1 upregulation in asthma is considered as a dogma by certain investigators in the field, the overall picture of the published litterature is not that clear and the cellular origin of this cytokine in the airways of asthmatics is still a contemporaneous debate. On the other hand, it is becoming clear that TGFβ1 signaling is increased in the lungs of asthmatics, which testifies the increased activity of this cytokine in asthma pathogenesis. The current work is an impartial and exhaustive compilation of the reported papers regarding the expression of TGFβ1 in human asthmatics. For the sake of comparison, several studies performed in animal models of the disease are also included. Inconsistencies observed in human studies are discussed and conclusions as well as trends from the current state of the litterature on the matter are proposed. Finally, the different points of regulation that can affect the amplitude of the TGFβ1 response are briefly revised and the possibility that TGFβ1 is disregulated at another level in asthma, rather than simply in its expression, is highlighted

Expression analysis of asthma candidate genes during human and murine lung development

<p>Abstract</p> <p>Background</p> <p>Little is known about the role of most asthma susceptibility genes during human lung development. Genetic determinants for normal lung development are not only important early in life, but also for later lung function.</p> <p>Objective</p> <p>To investigate the role of expression patterns of well-defined asthma susceptibility genes during human and murine lung development. We hypothesized that genes influencing normal airways development would be over-represented by genes associated with asthma.</p> <p>Methods</p> <p>Asthma genes were first identified via comprehensive search of the current literature. Next, we analyzed their expression patterns in the developing human lung during the pseudoglandular (gestational age, 7-16 weeks) and canalicular (17-26 weeks) stages of development, and in the complete developing lung time series of 3 mouse strains: A/J, SW, C57BL6.</p> <p>Results</p> <p>In total, 96 genes with association to asthma in at least two human populations were identified in the literature. Overall, there was no significant over-representation of the asthma genes among genes differentially expressed during lung development, although trends were seen in the human (Odds ratio, OR 1.22, confidence interval, CI 0.90-1.62) and C57BL6 mouse (OR 1.41, CI 0.92-2.11) data. However, differential expression of some asthma genes was consistent in both developing human and murine lung, e.g. <it>NOD1, EDN1, CCL5, RORA </it>and <it>HLA-G</it>. Among the asthma genes identified in genome wide association studies, <it>ROBO1</it>, <it>RORA, HLA-DQB1, IL2RB </it>and <it>PDE10A </it>were differentially expressed during human lung development.</p> <p>Conclusions</p> <p>Our data provide insight about the role of asthma susceptibility genes during lung development and suggest common mechanisms underlying lung morphogenesis and pathogenesis of respiratory diseases.</p

Variation in general supportive and preventive intensive care management of traumatic brain injury: a survey in 66 neurotrauma centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study

Abstract Background General supportive and preventive measures in the intensive care management of traumatic brain injury (TBI) aim to prevent or limit secondary brain injury and optimize recovery. The aim of this survey was to assess and quantify variation in perceptions on intensive care unit (ICU) management of patients with TBI in European neurotrauma centers. Methods We performed a survey as part of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. We analyzed 23 questions focused on: 1) circulatory and respiratory management; 2) fever control; 3) use of corticosteroids; 4) nutrition and glucose management; and 5) seizure prophylaxis and treatment. Results The survey was completed predominantly by intensivists (n = 33, 50%) and neurosurgeons (n = 23, 35%) from 66 centers (97% response rate). The most common cerebral perfusion pressure (CPP) target was > 60 mmHg (n = 39, 60%) and/or an individualized target (n = 25, 38%). To support CPP, crystalloid fluid loading (n = 60, 91%) was generally preferred over albumin (n = 15, 23%), and vasopressors (n = 63, 96%) over inotropes (n = 29, 44%). The most commonly reported target of partial pressure of carbon dioxide in arterial blood (PaCO2) was 36–40 mmHg (4.8–5.3 kPa) in case of controlled intracranial pressure (ICP) < 20 mmHg (n = 45, 69%) and PaCO2 target of 30–35 mmHg (4–4.7 kPa) in case of raised ICP (n = 40, 62%). Almost all respondents indicated to generally treat fever (n = 65, 98%) with paracetamol (n = 61, 92%) and/or external cooling (n = 49, 74%). Conventional glucose management (n = 43, 66%) was preferred over tight glycemic control (n = 18, 28%). More than half of the respondents indicated to aim for full caloric replacement within 7 days (n = 43, 66%) using enteral nutrition (n = 60, 92%). Indications for and duration of seizure prophylaxis varied, and levetiracetam was mostly reported as the agent of choice for both seizure prophylaxis (n = 32, 49%) and treatment (n = 40, 61%). Conclusions Practice preferences vary substantially regarding general supportive and preventive measures in TBI patients at ICUs of European neurotrauma centers. These results provide an opportunity for future comparative effectiveness research, since a more evidence-based uniformity in good practices in general ICU management could have a major impact on TBI outcome

A handheld fiber-optic probe to enable optical coherence tomography of oral soft tissue

This study presents a highly miniaturized, handheld probe developed for rapid assessment of soft tissue using optical coherence tomography (OCT). OCT is a non-invasive optical technology capable of visualizing the sub-surface structural changes that occur in soft tissue disease such as oral lichen planus. However, usage of OCT in the oral cavity has been limited, as the requirements for high-quality optical scanning have often resulted in probes that are heavy, unwieldy and clinically impractical. In this paper, we present a novel probe that combines an all-fiber optical design with a light-weight magnetic scanning mechanism to provide easy access to the oral cavity. The resulting probe is approximately the size of a pen (10 mm × 140 mm) and weighs only 10 grams. To demonstrate the feasibility and high image quality achieved with the probe, imaging was performed on the buccal mucosa and alveolar mucosa during routine clinical assessment of six patients diagnosed with oral lichen planus. Results show the loss of normal tissue structure within the lesion, and contrast this with the clear delineation of tissue layers in adjacent inconspicuous regions. The results also demonstrate the ability of the probe to acquire a three-dimensional data volume by manually sweeping across the surface of the mucosa. The findings of this study show the feasibility of using a small, lightweight probe to identify pathological features in oral soft tissue.Julia Walther, Jonas Golde, Marius Albrecht, Bryden C. Quirk, Loretta Scolaro, Rodney W. Kirk, Yuliia Gruda, Christian Schnabel, Florian Tetschke, Korinna Joehrens, Dominik Haim, Michaela Buckova, Jiawen Li, and Robert A. McLaughli